DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 5.580
EU - Europa 3.078
AS - Asia 1.345
SA - Sud America 135
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 10.170
Nazione #
US - Stati Uniti d'America 5.489
DE - Germania 685
IT - Italia 608
SG - Singapore 541
RU - Federazione Russa 450
CN - Cina 397
SE - Svezia 352
IE - Irlanda 281
HK - Hong Kong 167
UA - Ucraina 164
GB - Regno Unito 162
FI - Finlandia 157
BR - Brasile 108
CA - Canada 83
VN - Vietnam 64
FR - Francia 59
IN - India 46
AT - Austria 43
BE - Belgio 31
DK - Danimarca 30
TR - Turchia 29
ID - Indonesia 28
JP - Giappone 20
NL - Olanda 18
CL - Cile 14
IR - Iran 12
ES - Italia 8
ZA - Sudafrica 8
EU - Europa 7
UZ - Uzbekistan 6
GE - Georgia 5
IQ - Iraq 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
EC - Ecuador 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
HU - Ungheria 3
NG - Nigeria 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
KR - Corea 2
MU - Mauritius 2
NO - Norvegia 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.170
Città #
Ann Arbor 1.487
Chandler 410
Fairfield 392
Woodbridge 392
Singapore 377
Frankfurt am Main 369
Wilmington 337
Ashburn 279
Dublin 272
Houston 254
Milan 216
Santa Clara 178
Jacksonville 174
Hong Kong 165
Dearborn 160
Munich 152
Seattle 150
New York 137
Cambridge 132
Princeton 113
Helsinki 109
Nanjing 79
Shanghai 62
Lawrence 47
Altamura 38
Dong Ket 37
Vienna 35
Beijing 30
Lachine 30
Jakarta 28
Boardman 26
Council Bluffs 25
Brussels 24
Moscow 24
Andover 22
Grafing 21
Monza 21
Ottawa 21
San Diego 20
Guangzhou 19
Jinan 19
Nanchang 19
Pune 19
Fremont 18
Los Angeles 17
Rome 17
Nuremberg 16
Shenyang 15
Zhengzhou 15
Kocaeli 14
São Paulo 14
Toronto 14
Santiago 13
Changsha 12
Falls Church 12
London 12
Tianjin 12
Hebei 11
Hangzhou 10
Lissone 10
Edmonton 9
Jyväskylä 9
Leawood 9
Monmouth Junction 9
Jiaxing 8
Mountain View 8
Bari 7
Dallas 7
Detroit 7
Florence 7
Kunming 7
Turin 7
Bergamo 6
Chicago 6
Hiroshima 6
Segrate 6
Sesto San Giovanni 6
Taizhou 6
Tashkent 6
Auburn Hills 5
Brugherio 5
Dalmine 5
Düsseldorf 5
Hefei 5
Ningbo 5
University Park 5
Bologna 4
Brooklyn 4
Lappeenranta 4
Leipzig 4
Manila 4
Norwalk 4
Peschiera Borromeo 4
Quito 4
Rho 4
Samaná 4
Southwark 4
Squillace 4
Stockholm 4
Tokyo 4
Totale 7.380
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 389
Cardiac and neuronal HCN channelopathies 361
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 342
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 327
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 292
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 291
Effect of the ketogenic diet in excitable tissues 261
Generation and validation of algorithms to identify subjects with dementia using administrative data 258
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 250
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 239
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 220
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 210
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 208
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 204
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 203
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 203
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 200
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 198
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 195
Brain targets: can you believe your own eyes? 190
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 186
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 177
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 176
Cerebral Amyloid Angiopathy-Related Inflammation 174
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 173
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 171
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 171
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 170
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 169
Cerebral amyloid angiopathy-related inflammation: an emerging disease 166
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 166
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 162
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 161
HCN1 novel mutations in familiar generalized epilepsy 161
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 159
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 157
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 150
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 149
Epilptic seizures and psychogenic non-epileptic seizures 145
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 142
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 142
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 135
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 135
Complicanze neurologiche di malattie internistiche 132
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 128
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 125
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 122
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 120
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 118
Neurological soft signs are increased in migraine without aura: relationship with the affective status 106
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 104
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 103
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 101
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 96
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 95
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 92
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 88
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 87
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 86
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 77
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 74
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 72
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 53
Totale 10.717
Categoria #
all - tutte 37.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020274 0 0 0 0 0 0 0 0 0 121 117 36
2020/20211.643 75 88 181 161 121 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/20252.122 135 283 156 97 216 180 250 153 280 372 0 0
Totale 10.717